Movement Disorders Stocks List

Movement Disorders Stocks Recent News

Date Stock Title
Nov 1 MDT Medtronic (MDT) Outperforms Broader Market: What You Need to Know
Nov 1 MDT CMS grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral™ renal denervation catheter
Oct 31 JAZZ Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia
Oct 31 JAZZ Esperion Therapeutics (ESPR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Oct 31 MDT Edwards, Medtronic and Inari share trial data at TCT conference
Oct 31 MDT Boston Scientific’s Acurate Neo2 inferior to Edwards, Medtronic TAVR valves in study
Oct 31 NBIX Neurocrine Biosciences Inc (NBIX) Q3 2024 Earnings Call Highlights: Strong Sales and Strategic ...
Oct 31 NBIX Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
Oct 31 MDT Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)
Oct 30 NBIX Neurocrine Biosciences, Inc. (NBIX) Q3 2024 Earnings Call Transcript
Oct 30 NBIX Neurocrine stock jumps 9% on strong Ingrezza sales, stock buyback
Oct 30 JAZZ Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
Oct 30 NBIX Neurocrine (NBIX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Oct 30 NBIX Neurocrine Biosciences, Inc. 2024 Q3 - Results - Earnings Call Presentation
Oct 30 NBIX Neurocrine Biosciences (NBIX) Q3 Earnings Miss Estimates
Oct 30 NBIX Neurocrine: Q3 Earnings Snapshot
Oct 30 NBIX Neurocrine Biosciences bats Q3 revenue estimates, revises guidance
Oct 30 NBIX Neurocrine Biosciences Reports Third Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance
Oct 29 NBIX Neurocrine Biosciences Q3 2024 Earnings Preview
Oct 29 MDT Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock
Movement Disorders

Movement disorders are clinical syndromes with either an excess of movement or a paucity of voluntary and involuntary movements, unrelated to weakness or spasticity. Movement disorders are synonymous with basal ganglia or extrapyramidal diseases. Movement disorders are conventionally divided into two major categories- hyperkinetic and hypokinetic.
Hyperkinetic movement disorders refer to dyskinesia, or excessive, often repetitive, involuntary movements that intrude upon the normal flow of motor activity.
Hypokinetic movement disorders refer to akinesia (lack of movement), hypokinesia (reduced amplitude of movements), bradykinesia (slow movement) and rigidity. In primary movement disorders, the abnormal movement is the primary manifestation of the disorder. In secondary movement disorders, the abnormal movement is a manifestation of another systemic or neurological disorder.

Browse All Tags